Human papillomavirus serology and tobacco smoking in a community control group

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages

  Kelsey, Karl T ^a,b   Nelson, Heather H ^c   Kim, Stephanie ^a   Pawlita, Michael ^d   Langevin, Scott M ^a,e   Eliot, Melissa ^a   Michaud, Dominique S ^a   McClean, Michael ^f  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^f BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

HPV; Serology; Smoking

Indexed keywords

CAPSID PROTEIN L1; VIRUS ANTIBODY; VIRUS DNA;

ADULT; AGE; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; INCOME; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PAPILLOMAVIRUS INFECTION; POPULATION BASED CASE CONTROL STUDY; RACE; SELF REPORT; SEROLOGY; SEXUAL INTERCOURSE; SMOKING; BLOOD; CASE CONTROL STUDY; COMMUNITY CARE; GENETICS; HEAD AND NECK NEOPLASMS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; ODDS RATIO; PAPILLOMAVIRUS INFECTIONS; QUESTIONNAIRE; RISK FACTOR; STATISTICAL MODEL; UNITED STATES; VIROLOGY;

AGE FACTORS; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; COMMUNITY HEALTH SERVICES; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMANS; LOGISTIC MODELS; MALE; MASSACHUSETTS; MIDDLE AGED; ODDS RATIO; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SMOKING; SURVEYS AND QUESTIONNAIRES;

EID: 84923882436     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-014-0737-3     Document Type: Article

References (26)

1. Gillison ML, Alemany L, Snijders PJ, Chaturvedi A, Steinberg BM, Schwartz S, et al. Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis. Vaccine. 2012;30 Suppl 5:F34-54.
2. Ribeiro KB, Levi JE, Pawlita M, Koifman S, Matos E, Eluf-Neto J, et al. Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions. Int J Epidemiol. 2011;40(2):489-502.
3. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294-301.
4. Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA. 2012;307(7):693-703.
5. Schwartz SM, Daling JR, Doody DR, Wipf GC, Carter JJ, Madeleine MM, et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst. 1998;90(21):1626-36.
6. Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003;95(23):1772-83.
7. Applebaum KM, Furniss CS, Zeka A, Posner MR, Smith JF, Bryan J, et al. Lack of association of alcohol and tobacco with HPV16-associated head and neck cancer. J Natl Cancer Inst. 2007;99(23):1801-10.
8. Fakhry C, Gillison ML, D'Souza G. Tobacco use and oral HPV-16 infection. JAMA. 2014;312(14):1465-7.
9. Edelstein ZR, Schwartz SM, Hawes S, Hughes JP, Feng Q, Stern ME, et al. Rates and determinants of oral human papillomavirus infection in young men. Sex Transm Dis. 2012;39(11):860-7.
10. Lu B, Hagensee ME, Lee JH, Wu Y, Stockwell HG, Nielson CM, et al. Epidemiologic factors associated with seropositivity to human papillomavirus type 16 and 18 virus-like particles and risk of subsequent infection in men. Cancer Epidemiol Biomarkers Prev. 2010;19(2):511-6.
11. Dunne EF, Nielson CM, Hagensee ME, Papenfuss MR, Harris RB, Herrel N, et al. HPV 6/11, 16, 18 seroprevalence in men in two US cities. Sex Transm Dis. 2009;36(11):671-4.
12. Kreimer AR, Campbell CM, Lin HY, Fulp W, Papenfuss MR, Abrahamsen M, et al. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet. 2013;382(No.9895):877-87.
13. Stone KM, Karem KL, Sternberg MR, McQuillan GM, Poon AD, Unger ER, et al. Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis. 2002;186(10):1396-402.
14. Markowitz LE, Sternberg M, Dunne EF, McQuillan G, Unger ER. Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004. J Infect Dis. 2009;200(7):1059-67.
15. Kreimer AR, Alberg AJ, Viscidi R, Gillison ML. Gender differences in sexual biomarkers and behaviors associated with human papillomavirus-16, -18, and -33 seroprevalence. Sex Transm Dis. 2004;31(4):247-56.
16. Meschede W, Zumbach K, Braspenning J, Scheffner M, Benitez-Bribiesca L, Luande J, et al. Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer. J Clin Microbiol. 1998;36(2):475-80.
17. Sehr P, Muller M, Hopfl R, Widschwendter A, Pawlita M. HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase. J Virol Methods. 2002;106(1):61-70.
18. O'Rorke MA, Ellison MV, Murray LJ, Moran M, James J, Anderson LA. Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. Oral Oncol. 2012;48(12):1191-201.
19. Anantharaman D, Gheit T, Waterboer T, Abedi-Ardekani B, Carreira C, McKay-Chopin S, et al. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study. J Natl Cancer Inst. 2013;105(8):536-45.
20. Liang C, Marsit CJ, McClean MD, Nelson HH, Christensen BC, Haddad RI, et al. Biomarkers of HPV in head and neck squamous cell carcinoma. Cancer Res. 2012;72(19):5004-13.
21. Anderson KS, Wong J, D'Souza G, Riemer AB, Lorch J, Haddad R, et al. Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer. Br J Cancer. 2011;104(12):1896-905.
22. Smith EM, Pawlita M, Rubenstein LM, Haugen TH, Hamsikova E, Turek LP. Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer. Int J Cancer. 2010;127(1):111-7.
23. Wolf R, Freedman D. Cigarette smoking, sexually transmitted diseases, and HIV/AIDS. Int J Dermatol. 2000;39(1):1-9.
24. Bovill EG, Bild DE, Heiss G, Kuller LH, Lee MH, Rock R, et al. White blood cell counts in persons aged 65years or more from the Cardiovascular Health Study. Correlations with baseline clinical and demographic characteristics. Am J Epidemiol. 1996;143(11):1107-15.
25. Wood RC, MacDonald KL, White KE, Hedberg CW, Hanson M, Osterholm MT. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. JAMA. 1993;270(24):2935-9.
26. Mancini DA, Mendonca RM, Mendonca RZ, do Prado JA, Andrade Cde M. Immune response to vaccine against influenza in smokers, non-smokers and, in individuals holding respiratory complications. Boll Chim Farm. 1998;137(1):21-5.